WallStreetZenWallStreetZen

NYSEMKT: CATX
Perspective Therapeutics Inc Stock Ownership - Who owns Perspective Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Perspective Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Heidi HensonDirector2024-12-0425,975$3.85
$100.00kBuy
Johan M. SpoorCEO2024-12-048,000$3.77
$30.14kBuy
Robert F. Williamson IiiDirector2024-11-252,619$3.67
$9.61kBuy
Jonathan Robert HuntChief Financial Officer2024-11-2510,000$3.88
$38.80kBuy
Jonathan Robert HuntChief Financial Officer2024-11-252,400$3.60
$8.64kBuy
Robert F. Williamson IiiDirector2024-11-252,619$3.67
$9.61kBuy
Jonathan Robert HuntChief Financial Officer2024-11-25400$3.55
$1.42kBuy
Robert F. Williamson IiiDirector2024-11-253,647$3.62
$13.20kBuy
Johan M. SpoorCEO2024-11-256,600$3.80
$25.08kBuy
Johan M. SpoorCEO2024-11-255,400$3.80
$20.52kBuy

1 of 3

CATX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CATX insiders and whales buy or sell their stock.

CATX Shareholders

What type of owners hold Perspective Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lantheus Alpha Therapy LLC172.77%116,773,394$302.44MInsider
Fmr LLC14.84%10,027,301$25.97MInstitution
Blackrock Inc6.07%4,105,247$10.63MInstitution
Vanguard Group Inc4.65%3,144,867$8.15MInstitution
Deerfield Management Company LP Series C4.35%2,938,754$7.61MInstitution
Avidity Partners Management LP3.99%2,694,600$6.98MInstitution
Octagon Capital Advisors LP3.41%2,304,752$5.97MInstitution
Nicholson Wealth Management Group LLC2.38%1,609,283$4.17MInstitution
Markus Puhlmann2.04%1,375,425$3.56MInsider
Affinity Asset Advisors LLC1.92%1,300,000$3.37MInstitution

1 of 3

CATX vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CATX28.06%71.94%Net Buying
LNSR30.92%50.71%Net BuyingNet Selling
MYO42.50%10.37%Net SellingNet Selling
PROF55.85%0.00%
BWAY17.72%0.00%
View Top Medical Device Stocks

Perspective Therapeutics Stock Ownership FAQ

Who owns Perspective Therapeutics?

Perspective Therapeutics (NYSEMKT: CATX) is owned by 69.90% institutional shareholders, 179.26% Perspective Therapeutics insiders, and 0.00% retail investors. Lantheus Alpha Therapy LLC is the largest individual Perspective Therapeutics shareholder, owning 116.77M shares representing 172.77% of the company. Lantheus Alpha Therapy LLC's Perspective Therapeutics shares are currently valued at $302.44M.

If you're new to stock investing, here's how to buy Perspective Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.